20 Dec, EOD - Indian

SENSEX 78041.59 (-1.49)

Nifty 50 23587.5 (-1.52)

Nifty Bank 50759.2 (-1.58)

Nifty IT 43771.05 (-2.63)

Nifty Midcap 100 56906.75 (-2.82)

Nifty Next 50 68702.65 (-2.72)

Nifty Pharma 22501.85 (-0.86)

Nifty Smallcap 100 18714.3 (-2.19)

20 Dec, EOD - Global

NIKKEI 225 38701.9 (-0.29)

HANG SENG 19720.7 (-0.16)

S&P 6008.5 (1.05)

Login/Signup
LOGIN HERE
Cancel

Global Health Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543654 | NSE Symbol : MEDANTA | ISIN : INE474Q01031 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
07-Nov-2024 14-Nov-2024 Quarterly Results Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2024. Outcome of Board Meeting held on November 14, 2024 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). (As Per Bse Announcement Dated on 14.11.2024)
06-Nov-2024 06-Nov-2024 Others Dear Sir(s), We wish to inform you that the Board of Directors of the Company, at their meeting held today i.e. Wednesday, November 6, 2024, have approved signing of definitive agreement (s) with Dr. Narayan Dutt Shrimali Foundation International Charitable Trust Society (Society), to operate and manage ~750 bedded hospital in Pitampura, New Delhi. Read less..
31-Jul-2024 08-Aug-2024 Quarterly Results Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the first quarter ended June 30 2024. Dear Sir(s), We would like to inform you that the Board of Directors of Global Health Limited ('GHL/Company') at its meeting held today i.e. Thursday, August 8, 2024, has inter alia, approved: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the First Quarter ended June 30, 2024 as enclosed. . 2. Notice of 20th Annual General Meeting of the Company to be held on Thursday, September 19, 2024 at 12:00 Noon through Video Conferencing/Other Audio Video Means ('VC/OAVM') Facility; and 3. Construction of service apartments/guest house as part of 'Medanta-The Medicity' campus which will also include necessary facilities for the international and domestic patients and their families. (As per BSE Announcement Dated on 08/08/2024)
24-Jul-2024 24-Jul-2024 Others We wish to inform you that the Board of Directors of the Company, at their meeting held today i.e. Wednesday, July 24, 2024, have approved the acquisition of land parcel measuring 8859.24 sq. meters, on lease basis, offered by Mumbai Housing and Area Development Authority (MHADA) under online e-tenders, at a bid amount of Rs 125.11 crores (approx.), situated at Mauje-Oshiwara, Jogeshwari, CTS No. 31, 32 (part), 33 (part), 37 (part), Mumbai, Maharashtra.
07-May-2024 17-May-2024 Accounts Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended March 31 2024. The Board of Directors of the Company at its meeting held today i.e. Friday, May 17, 2024, has inter alia, considered and approved the following: a) Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended March 31, 2024. ('Results'). The Certified copies of Result along with the Audit Reports from the Statutory Auditors of the Company are enclosed herewith as Exhibit A. Declaration in respect of Audit Reports with unmodified opinion is enclosed herewith as Exhibit B. b) Recommendation of payment of Commission to Independent Directors for approval of Shareholders to be obtained through Postal Ballot. Notice of Postal Ballot, will be sent to all the Shareholders of the Company whose names appear on the Register of Members/List of Beneficial Owners as received from Depositories, as on Friday, May 17, 2024 (''cut-off date''). Audited Standalone and Consolidated Results for Financial Year ended March 31, 2024 (As Per BSE Announcement Dated on 17.05.2024)
21-Mar-2024 21-Mar-2024 Scheme of Amalgamation The Board in its meeting held today, has approved the scheme of Amalgamation between the Company and Medanta Holdings Private Limited, wholly-owned subsidiary of the Company. The Board at its meeting today, has approved the Incorporation of Section 8 Company, by subscribing 100% Equity Share Capital of the said Proposed Company.
30-Jan-2024 08-Feb-2024 Quarterly Results Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve the Unaudited Financial Results (both standalone and consolidated) of the Company for the third quarter and nine months ended December 31 2023. Dear Sir(s), We would like to inform you that the Board of Directors of Global Health Limited ('GHL/Company') at its meeting held today i.e. Thursday, February 8, 2024, inter-alia, approved the Unaudited Standalone & Consolidated Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2023 ('Results'), Attached herewith. Appointment of KMP/CFO w.e.f. February 8, 2024. (As per BSE Announcement Dated on 08/02/2024)
30-Oct-2023 09-Nov-2023 Quarterly Results Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2023. Special Purpose Company to be incorporated jointly by DLF Limited and GHL, in which both companies will have 50.50 Equity Shareholding. We would like to inform you that the Board of Directors of Global Health Limited ('GHL/Company') at its meeting held today i.e. Thursday, November 9, 2023, inter-alia, has approved the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half year ended September 30, 2023 ('Results'). The certified copies of Results along with Limited Review Reports from the Statutory Auditors M/s Walker Chandiok & Co LLP, Chartered Accountants thereon, are enclosed herewith as Exhibit, Further, in continuance with our earlier intimation dated August 10, 2023, Re. development of a 400 bed multi-specialty hospital in Delhi along with M/s DLF Limited, please note that, the Board of Directors of the Company at its meeting held today has approved execution of definitive agreement for jointly incorporation of Special Purpose Vehicle (SPV) with M/s DLF Limited. The details is attached. (As Per BSE Announcement Dated on 09/11/2023)
01-Aug-2023 10-Aug-2023 Quarterly Results Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended 30th June 2023. Further in accordance with the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code for prevention of Insider Trading the Trading Window of the Company is already closed from 1st July 2023 and will re-open after 48 hours from the declaration of above said results. Outcome of Board Meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') (As Per BSE Announcement dated on 10.08.2023)
19-May-2023 27-May-2023 Quarterly Results Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 inter alia to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended 31st March 2023. Further in accordance with the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code for prevention of Insider Trading the Trading Window of the Company is already closed from 1st April 2023 and will re-open after 48 hours from the declaration of above said results. We would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday, 27th May, 2023, has inter alia, considered and approved the following: 1) Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023. ('Results'). The Certified copies of Results along with Audit Reports from the Statutory Auditors of the Company and Declaration on Auditor''s Report with unmodified opinion pursuant to Regulation 33(3) (d) of Listing Regulations read with SEBI circular No. CIR/CFD/CMD/56/2016, dated May 27, 2016 are enclosed herewith. 2) Allotment of 9,710 Equity Shares of face value of Rs. 2/- each to 1 (One) eligible employee upon exercise of options vested under ESOP 2016 Scheme. The meeting of the Board of Directors commenced at 4.00 P.M. and concluded at 5.50 P.M. (As Per BSE Announcement Dated on 27.05.2023)
27-Mar-2023 27-Mar-2023 Others This is with reference to the letter Ref. No.- GHL/2022-23/EXCH/022 dated 13th February, 2023, wherein the Board of Directors of the Company has approved the binding Term Sheet for a new hospital at Indore on Operation & Management basis. In this regard, the Board of Directors of the Company at its Board Meeting held today i.e. Monday, 27th March, 2023, has extended the validity of Term Sheet till June 23, 2023 (earlier 60 days from date of execution) to execute necessary agreement subject to completion of due diligence. The Company has appointed a law firm, JSA advocates & solicitors, for the purposes of conducting the said due diligence and the same is underway. There are no changes in the disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on February 13, 2023 except above. This is with reference to the letter Ref. No.- GHL/2022-23/EXCH/022 dated 13th February, 2023, wherein the Board of Directors of the Company has approved the binding Term Sheet for a new hospital at Indore on Operation & Management basis. In this regard, the Board of Directors of the Company at its Board Meeting held today i.e. Monday, 27th March, 2023, has extended the validity of Term Sheet till June 23, 2023 (earlier 60 days from date of execution) to execute necessary agreement subject to completion of due diligence. The Company has appointed a law firm, JSA advocates & solicitors, for the purposes of conducting the said due diligence and the same is underway. There are no changes in the disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on February 13, 2023 except above. (As Per BSE Announcement Dated on 27.03.2023)
04-Feb-2023 13-Feb-2023 Quarterly Results Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2022. Dear Sir(s), We would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, February 13, 2023, has inter alia, approved: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended December 31, 2022 (Results); and 2. The binding term sheet for a new hospital at Indore on Operation & Management basis. The details as required under Regulation 30 are in Exhibit. The certified copies of Results along with Limited Review Reports from the Statutory Auditors M/s Walker Chandiok & Co LLP, Chartered Accountants thereon, are enclosed herewith pursuant to Regulation 33 of Listing Regulations. (As Per BSE Announcement dated on 13.02.2023)
22-Dec-2022 22-Dec-2022 Change in Directors Dear Sir/Madam, With reference to the above, please take note that the Board of Directors in their meeting held today i.e. December 22, 2022 has approved the Amendment in Articles of Association of the Company, as per the attachment. Dear Sir/Madam, With reference to the above, please take note that the Board of Directors in their meeting held today i.e. December 22, 2022 has approved the Appointment of Mr. Pankaj Prakash Sahni (DIN:07132999) as Additional Director and Whole Time Director, for a period of Five (5) Years with effect from 1st January, 2023, as detailed in the attachment. Dear Sir/Madam, With reference to the above, please take note that the Board of Directors in their meeting held today i.e December 22, 2022 has approved the following item(s) : a) Amendment in Articles of Association of the Company. b) Appointment of Mr. Pankaj Prakash Sahni (DIN:07132999) as Additional Director and Whole Time Director, for a period of Five (5) Years with effect from 1st January, 2023. c) Ratification of ESOP 2016 Scheme and ESOP 2021 Scheme of the Company Please also take note that the above are subject to approval of Shareholders proposed to be obtained by means Postal Ballot process, the Notice of which, will be sent to all the Members of the Company whose names appear on the Register of Members/List of Beneficial Owners as received from Depositories, as on Friday, 16th December, 2022 (''cut-off date'').
1